Pfizer Inc - Company Profile
Powered by 
All the sales intelligence you need on Pfizer Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Pfizer Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Pfizer Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreView up-to-date information on Pfizer Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390252A1 | Application | Use of riluzole prodrugs to treat ataxias | A61K31/428; A61K9/20; A61P25/00 | December 07, 2023 |
| US20230391835A1 | Application | Compositions relating to a mutant clostridium difficile toxin and methods thereof | C12N15/74; C12N9/1051; C12N9/99; A61K39/08; C07K14/33; C07K16/1282; C07K2317/33; C07K2317/76; C07K2317/92 | December 07, 2023 |
| US20230390307A1 | Application | Peg-free aqueous suspensions for parenteral administration of a corticosteroid | A61K31/57; A61K31/573; A61K47/22; A61K9/10 | December 07, 2023 |
| EP3572405B9 | Grant | Benzoimidazol-1,2-yl-amide als kv7-kanalaktivatoren | A61P25/06; A61P25/08; A61P29/00; C07D235/30; C07D401/04; C07D401/12; C07D403/04; C07D405/12; C07D413/04 | December 06, 2023 |
| EP3209291B1 | Grant | Verfahren zur behandlung von leiden im zusammenhang mit dem pgi2-rezeptor | A61K31/325; A61K31/33; A61K9/148; A61K9/20; A61K9/48; A61P9/12 | December 06, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer